COVID-19: Vaccine policy statements and clinical guidance

Guidance and policy standards for the COVID-19 Vaccine Immunisation Programme.

On this page:


Service standards

To assure consumer safety and a high-quality service, these New Zealand COVID-19 Vaccine Immunisation Service Standards (the Standards) have been prepared to specify the minimum requirements of the COVID-19 Vaccine Immunisation Programme.

COVID-19 Vaccine Immunisation Service Standards (PDF, 444 KB)
COVID-19 Vaccine Immunisation Service Standards (Word, 354 KB)
Version 1.0 – last updated October 2021


COVID-19 vaccine use and waste

COVID-19 vaccine supplies are carefully managed, and the Ministry of Health has robust processes in place to minimise vaccine waste at different phases of delivery. This policy statement sets out our focus on ensuring the best use of the available vaccine.

COVID-19 Vaccine Use and Waste Policy Statement (PDF, 231 KB)
COVID-19 Vaccine Use and Waste Policy Statement (Word, 133 KB)
Version 3.0 – last updated January 2022


COVID-19 vaccine third primary dose

The Ministry of Health recommends that severely immunocompromised people over the age of 12 receive a third primary dose of the COVID-19 vaccine. This policy statement and clinical guidance lays out this recommendation and its implementation.

COVID-19 vaccine third primary dose policy statement (PDF, 229 KB)
COVID-19 vaccine third primary dose policy statement (Word, 511 KB)
Version 4 – last updated May 2022


Informed consent for young people

This policy provides guidance on informed consent for the administration of the COVID-19 vaccine to our young people aged 12-15 years. It also identifies the different requirements for school, community and facility or residential care-based vaccination.

COVID-19 Vaccine Informed Consent for Young People Aged 12-15 Years Policy Statement (PDF, 176 KB)
Version 1.0 – last updated August 2021


Trial vaccinations and vaccination certificates

This document is a policy statement on the decisions and implications for consumers considering or participating in Medsafe approved COVID-19 clinical trial in Aotearoa New Zealand. This includes decisions around access to approved national vaccines, recording trial vaccines in the COVID-19 Immunisation Register (CIR), access to the domestic vaccination pass or international certificate, requesting a temporary medical exemption and the implications of being under the COVID-19 Public Health Response (Vaccination) Order 2021.

COVID-19 trial vaccinations and vaccination certificates policy statement (PDF, 182 KB)
COVID-19 trial vaccinations and vaccination certificates policy statement (Word, 131 KB)
Version 1.0 – last updated November 2021


Administering COVID-19 vaccines with other vaccines on the immunisation schedule

This policy statement advises on the administration of COVID-19 vaccines with other vaccines included on the immunisation schedule.

Concomitant administration of COVID-19 vaccines with other vaccines on the national immunisation schedule (PDF, 197 KB)
Concomitant administration of COVID-19 vaccines with other vaccines on the national immunisation schedule (Word, 125 KB)
Version 2.0 – last updated April 2022


Booster vaccinations

This policy statement advises on the use of booster doses of COVID-19 vaccines in Aotearoa New Zealand.

COVID-19 booster vaccination policy statement (PDF, 220 KB)
COVID-19 booster vaccination policy statement (Word, 142 KB)
Version 4 – last updated 7 April 2022


Novavax vaccine guidance and policies

This document provides a policy statement on the use of the Novavax vaccine in Aotearoa New Zealand.

Novavax COVID-19 vaccine policy statement, clinical criteria and guidance (PDF, 249 KB)
Novavax COVID-19 vaccine policy statement, clinical criteria and guidance (Word, 145 KB)
Version 1 – published 9 March 2022


AstraZeneca vaccine guidance and policies

This document provides a policy statement on the use of the AstraZeneca vaccine in Aotearoa New Zealand.

AstraZeneca COVID-19 vaccine policy statement, clinical criteria and guidance (PDF, 252 KB)
AstraZeneca COVID-19 vaccine policy statement, clinical criteria and guidance (Word, 144 KB)
Version 1.3 – last updated 25 February 2022


Definition of fully vaccinated within Aotearoa New Zealand

This policy statement sets out the definition to be fully vaccinated within Aotearoa New Zealand as it relates to the requirements of the COVID-19 Protection Framework.

Fully vaccinated against COVID-19 within Aotearoa New Zealand policy statement (PDF, 225 KB)
Fully vaccinated against COVID-19 within Aotearoa New Zealand policy statement (Word, 146 KB)
Version 2 – last updated February 2022


COVID-19 vaccine for children aged 5–11 years policy statement

This document provides a policy statement on the rollout of the paediatric vaccine to children aged 5 to 11 years. It also identifies the requirements for consent at community and residential care or facility-based vaccination sites.

COVID-19 vaccine for children aged 5–11 years policy statement (PDF, 239 KB)
COVID-19 vaccine for children aged 5–11 years policy statement (Word, 519 KB)
Version 2.0 – last updated May 2022

Back to top